secwatch.observer — SEC 8-K summary
======================================

Issuer:     KIORA PHARMACEUTICALS INC (KPRX)
CIK:        0001372514
Form:       8-K
Filed at:   2024-02-12T23:59:59+00:00
Accession:  0001372514-24-000013
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kiora Pharmaceuticals furnishes updated investor presentation; no material new information disclosed
--------------------------------------------------------------------------------

- Filed an updated corporate overview presentation dated H1 2024 under Regulation FD.
- Presentation is available for use in investor meetings and web postings.
- No financial results, clinical data, or operational changes were announced in the filing.
- Ticker KPRX; the filing does not contain any guidance or material events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000013/0001372514-24-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1372514/000137251424000013/kprx-20240212.htm
  HTML page:      https://secwatch.observer/filing/0001372514-24-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer